Bassan Merav 4
4 · BiomX Inc. · Filed Oct 31, 2023
Insider Transaction Report
Form 4
BiomX Inc.PHGE
Bassan Merav
Chief Development Officer
Transactions
- Award
Common Stock Options - Right to Buy
2023-10-29+189,997→ 0 totalExercise: $0.28Exp: 2029-10-10→ Common Stock (0 underlying) - Disposition to Issuer
Common Stock Options - Right to Buy
2023-10-29−189,997→ 0 totalExercise: $10.00Exp: 2029-10-10→ Common Stock (0 underlying)
Footnotes (1)
- [F1]The reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 10/10/2019 and provides for vesting over four years, with 25% of the shares subject to the option vested on 10/10/2020, and the remainder vesting in 12 equal quarterly installments over three years; provided, however, none of the "new" options may be exercised prior to October 29, 2024.